Argan oil prevents prothrombotic complications by lowering lipid levels and platelet aggregation, enhancing oxidative status in dyslipidemic patients from the area of Rabat (Morocco)

[1]  R. Lamuela-Raventós,et al.  The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled, trial. , 2013, Clinical nutrition.

[2]  K. Kelley,et al.  Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia. , 2013, Nutrition.

[3]  L. Ulmann,et al.  The role of Odontella aurita, a marine diatom rich in EPA, as a dietary supplement in dyslipidemia, platelet function and oxidative stress in high-fat fed rats , 2012, Lipids in Health and Disease.

[4]  A. Ziyyat,et al.  Antithrombotic activity of argan oil: an in vivo experimental study. , 2012, Nutrition.

[5]  A. Georgescu,et al.  Platelet dysfunction in vascular pathologies and how can it be treated. , 2012, Thrombosis research.

[6]  A. Ziyyat,et al.  Prevention of Chemically Induced Diabetes Mellitus in Experimental Animals by Virgin Argan Oil , 2012, Phytotherapy research : PTR.

[7]  G. Horgan,et al.  In vitro anti-platelet effects of simple plant-derived phenolic compounds are only found at high, non-physiological concentrations. , 2011, Molecular nutrition & food research.

[8]  K. Tucker,et al.  Coronary heart disease prevention: nutrients, foods, and dietary patterns. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[9]  P. Kolh,et al.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, European heart journal.

[10]  C. Morrell,et al.  Platelets as initiators and mediators of inflammation at the vessel wall. , 2011, Thrombosis research.

[11]  Ian Graham,et al.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, Atherosclerosis.

[12]  D. Guillaume,et al.  Therapeutic potential of argan oil: a review , 2010, The Journal of pharmacy and pharmacology.

[13]  D. Rader,et al.  Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review. , 2010, Journal of clinical lipidology.

[14]  C. Schneider.  Lipids in health and disease. , 2010, Molecular nutrition & food research.

[15]  L. Badimón,et al.  Lipoproteínas, plaquetas y aterotrombosis , 2009 .

[16]  G. Vilahur,et al.  Lipoproteins, platelets and atherothrombosis. , 2009, Revista espanola de cardiologia.

[17]  E. Levy,et al.  Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity. , 2009, Metabolism: clinical and experimental.

[18]  F. Blanco-Vaca,et al.  New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. , 2009, Atherosclerosis.

[19]  A. Ziyyat,et al.  Effect of Argan Oil on Platelet Aggregation and Bleeding Time: A Beneficial Nutritional Property , 2008 .

[20]  C. McNeal,et al.  Metabolic syndrome and dyslipidemia in youth. , 2008, Journal of clinical lipidology.

[21]  D. Laaksonen,et al.  Dietary fatty acids and cardiovascular disease: an epidemiological approach. , 2008, Progress in lipid research.

[22]  D. Atar,et al.  Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease , 2008, Journal of Thrombosis and Thrombolysis.

[23]  H. Berrougui,et al.  Antiatherogenic activity of extracts of Argania spinosa L. pericarp: beneficial effects on lipid peroxidation and cholesterol homeostasis. , 2007, Canadian journal of physiology and pharmacology.

[24]  E. Schaefer,et al.  Hypertriglyceridemia and cardiovascular risk reduction. , 2007, Clinical therapeutics.

[25]  S. Grundy.  Controversy in Clinical Endocrinology Metabolic Syndrome: a Multiplex Cardiovascular Risk Factor Mets as a Multiplex Cardiovascular Risk Factor , 2022 .

[26]  Abdelouahed Khalil,et al.  Argan oil: which benefits on cardiovascular diseases? , 2006, Pharmacological research.

[27]  P. Williams,et al.  Plant Sterols as Dietary Adjuvants in the Reduction of Cardiovascular Risk: Theory and Evidence , 2006, Vascular health and risk management.

[28]  P. Haddad,et al.  Insulin-sensitizing and Anti-proliferative Effects of Argania spinosa Seed Extracts , 2006, Evidence-based complementary and alternative medicine : eCAM.

[29]  H. Berrougui,et al.  Phenolic-extract from argan oil (Argania spinosa L.) inhibits human low-density lipoprotein (LDL) oxidation and enhances cholesterol efflux from human THP-1 macrophages. , 2006, Atherosclerosis.

[30]  A. Khalil,et al.  Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[31]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[32]  P Mata,et al.  International conference on the healthy effect of virgin olive oil , 2005, European journal of clinical investigation.

[33]  A. Adlouni,et al.  Nutritional Intervention Study with Argan Oil in Man: Effects on Lipids and Apolipoproteins , 2005, Annals of Nutrition and Metabolism.

[34]  H. Berrougui,et al.  Argan (Argania spinosa) oil lowers blood pressure and improves endothelial dysfunction in spontaneously hypertensive rats. , 2004, The British journal of nutrition.

[35]  R. Solà,et al.  Evidence of hypolipemiant and antioxidant properties of argan oil derived from the argan tree (Argania spinosa). , 2004, Clinical nutrition.

[36]  K. Ley,et al.  Role of platelets in the development of atherosclerosis. , 2004, Trends in cardiovascular medicine.

[37]  H. Berrougui,et al.  Hypolipidemic and hypocholesterolemic effect of argan oil (Argania spinosa L.) in Meriones shawi rats. , 2003, Journal of ethnopharmacology.

[38]  Z Charrouf,et al.  Consumption of argan oil (Morocco) with its unique profile of fatty acids, tocopherols, squalene, sterols and phenolic compounds should confer valuable cancer chemopreventive effects , 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[39]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[40]  M. Raeini-Sarjaz,et al.  Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. , 2000, Journal of lipid research.

[41]  J. Spivak,et al.  Commentary on and reprint of Born GVR, Aggregation of blood platelets by adenosine diphosphate and its reversal, in Nature (1962) 194:927–929 , 2000 .

[42]  P. Kris-Etherton,et al.  High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. , 1999, The American journal of clinical nutrition.

[43]  Z Charrouf,et al.  Ethnoeconomical, ethnomedical, and phytochemical study of Argania spinosa (L.) Skeels. , 1999, Journal of ethnopharmacology.

[44]  P. Calder,et al.  Cholesterol reduction using manufactured foods high in monounsaturated fatty acids: a randomized crossover study , 1999, British Journal of Nutrition.

[45]  D. Waters,et al.  Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. , 1995, Circulation.

[46]  G. Davı̀,et al.  Thromboxane Biosynthesis, Neutrophil and Coagulative Activation in Type IIa Hypercholesterolemia , 1995, Thrombosis and Haemostasis.

[47]  D. Betteridge,et al.  Elevated Levels of Authentic Plasma Hydroperoxides in NIDDM , 1995, Diabetes.

[48]  U. Das.  Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. , 1995, Prostaglandins, leukotrienes, and essential fatty acids.

[49]  I. Jialal,et al.  The Effect of α-Tocopherol Supplementation on LDL Oxidation: A Dose-Response Study , 1995 .

[50]  R. Takada,et al.  Dietary gamma-linolenic acid-enriched oil reduces body fat content and induces liver enzyme activities relating to fatty acid beta-oxidation in rats. , 1994, The Journal of nutrition.

[51]  C. Rice-Evans,et al.  Free radical-lipid interactions and their pathological consequences. , 1993, Progress in lipid research.

[52]  R. Cheung,et al.  Glutathione metabolic enzyme activities in diabetic platelets as a function of glycemic control. , 1992, Thrombosis research.

[53]  D. Kelley,et al.  Platelet aggregation in humans is affected by replacement of dietary linoleic acid with oleic acid. , 1991, American Journal of Clinical Nutrition.

[54]  A. Dutta-Roy,et al.  Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets. , 1987, The Journal of biological chemistry.

[55]  P. Ducimetiere.  [Hyperlipidemia and coronary disease]. , 1985, Revue d'epidemiologie et de sante publique.

[56]  M. Lagarde,et al.  A simple and efficient method for platelet isolation from their plasma. , 1980, Thrombosis research.

[57]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[58]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[59]  W. Richmond.  Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. , 1973, Clinical chemistry.

[60]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[61]  P. Trinder.  Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor , 1969 .

[62]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.

[63]  G. Born,et al.  Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.